TGTX opens lower but pares losses on Novartis data, Wainwright note
TG Therapeutics (TGTX) opened lower Tuesday, then pared losses as investors digested Novartis multiple sclerosis pill data and an H.C. Wainwright note from Emily Bodnar saying the results do not threaten Briumvi.